108 related articles for article (PubMed ID: 11380428)
1. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis.
Amini-Nekoo A; Futers TS; Moia M; Mannucci PM; Grant PJ; Ariëns RA
Br J Haematol; 2001 May; 113(2):537-43. PubMed ID: 11380428
[TBL] [Abstract][Full Text] [Related]
2. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter.
Amini Nekoo A; Iles D
Thromb Res; 2008; 121(6):813-9. PubMed ID: 17931693
[TBL] [Abstract][Full Text] [Related]
3. Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis.
Ariëns RA; Alberio G; Moia M; Mannucci PM
Thromb Haemost; 1999 Feb; 81(2):203-7. PubMed ID: 10063992
[TBL] [Abstract][Full Text] [Related]
4. Association of Asn221Ser mutation in tissue factor pathway inhibitor-beta with plasma total tissue factor pathway inhibitor level.
Ishikawa J; Okada H; Kato H; Takeshita S; Honda S; Kawasaki T; Suehisa E; Tsuji H; Madoiwa S; Sakata Y; Kojima T; Murata M; Ikeda Y; Kokubo Y; Okamura T; Tomoike H; Miyata T
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):22-6. PubMed ID: 20523161
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study.
Cao X; Su Y; Zhang W; Zhao H; Wen M; Lu S; Zhao Y; Chen Y; Liu L; Zang X; Wu J
Clin Appl Thromb Hemost; 2021; 27():10760296211063877. PubMed ID: 34898295
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.
Opstad TB; Eilertsen AL; Høibraaten E; Skretting G; Sandset PM
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):516-21. PubMed ID: 20453636
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms with plasma TFPI level: Boon or curse for DVT patients - Study from India.
Kamal K; Amit S; Kanwaljeet S; Ravi R; Hareram P; Ravi K; Kumar KV; Pravas M; Renu S
Blood Cells Mol Dis; 2017 Jul; 66():31-36. PubMed ID: 28810169
[TBL] [Abstract][Full Text] [Related]
8. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.
Dahm A; Van Hylckama Vlieg A; Bendz B; Rosendaal F; Bertina RM; Sandset PM
Blood; 2003 Jun; 101(11):4387-92. PubMed ID: 12560220
[TBL] [Abstract][Full Text] [Related]
9. Coagulation Factor Hyperfunction After Subarachnoid Hemorrhage Induces Deep Venous Thrombosis.
Miao W; Zhao K; Deng W; Teng J
World Neurosurg; 2018 Feb; 110():e46-e52. PubMed ID: 29196248
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.
Dahm A; Rosendaal FR; Andersen TO; Sandset PM
Br J Haematol; 2006 Feb; 132(3):333-8. PubMed ID: 16409298
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPI.
Moatti D; Seknadji P; Galand C; Poirier O; Fumeron F; Desprez S; Garbarz M; Dhermy D; Arveiler D; Evans A; Luc G; Ruidavets JB; Ollivier V; Hakim J; Aumont MC; de Prost D
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):862-9. PubMed ID: 10195910
[TBL] [Abstract][Full Text] [Related]
12. Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer.
Fei X; Wang H; Yuan W; Wo M; Jiang L
Biomed Res Int; 2017; 2017():8983763. PubMed ID: 28246607
[TBL] [Abstract][Full Text] [Related]
13. The 536C-->T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis.
Kleesiek K; Schmidt M; Götting C; Schwenz B; Lange S; Müller-Berghaus G; Brinkmann T; Prohaska W
Thromb Haemost; 1999 Jul; 82(1):1-5. PubMed ID: 10456444
[TBL] [Abstract][Full Text] [Related]
14. A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels.
Moatti D; Haidar B; Fumeron F; Gauci L; Boudvillain O; Seknadji P; Olliver V; Aumont MC; de Prost D
Thromb Haemost; 2000 Aug; 84(2):244-9. PubMed ID: 10959696
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
[TBL] [Abstract][Full Text] [Related]
16. Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.
Zakai NA; Lutsey PL; Folsom AR; Heckbert SR; Cushman M
Thromb Haemost; 2010 Aug; 104(2):207-12. PubMed ID: 20431849
[TBL] [Abstract][Full Text] [Related]
17. The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.
Ameziane N; Seguin C; Borgel D; Fumeron F; Moatti D; Alhenc-Gelas M; Grandchamp B; Aiach M; Emmerich J; de Prost D
Thromb Haemost; 2002 Aug; 88(2):195-9. PubMed ID: 12195688
[TBL] [Abstract][Full Text] [Related]
18. Association of TFPI polymorphisms rs8176592, rs10931292, and rs10153820 with venous thrombosis: A meta-analysis.
Zhang Y; Pang A; Zhao L; Guo Q; Zhang Z; Zhu X; Wei R; Yin X; Wang B; Li X
Medicine (Baltimore); 2019 Mar; 98(12):e14978. PubMed ID: 30896671
[TBL] [Abstract][Full Text] [Related]
19. Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke.
Duering C; Kosch A; Langer C; Thedieck S; Nowak-Göttl U
Thromb Haemost; 2004 Oct; 92(4):707-12. PubMed ID: 15467899
[TBL] [Abstract][Full Text] [Related]
20. MMP-3-1612 polymorphism - a risk factor for deep venous thrombosis formation.
Yu LM; Li NX; Sheng YG
Vasa; 2016; 45(3):233-9. PubMed ID: 27129069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
